The University of Chicago Header Logo

Connection

Rolf Barth to Risk Assessment

Back to Details
This is a "connection" page, showing publications Rolf Barth has written about Risk Assessment.
Rolf Barth
Connection Strength
0.252
Risk Assessment
  1. How to Help Patients Considering VCA. AMA J Ethics. 2019 11 01; 21(11):E960-967.
    View in: PubMed
    Score: 0.100
  2. Minimally invasive donor nephrectomy: current state of the art. Langenbecks Arch Surg. 2018 Sep; 403(6):681-691.
    View in: PubMed
    Score: 0.092
  3. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15. Transplantation. 2020 04; 104(4):762-769.
    View in: PubMed
    Score: 0.026
  4. Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation. Transplantation. 2017 07; 101(7):1551-1558.
    View in: PubMed
    Score: 0.021
  5. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford). 2010 Dec; 12(10):657-63.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.